Effects of E2, P4 and LH Levels on the Day of Transfer and Endometrial Cavity Thickness on Implantation Success in Patients With Frozen-thawed Embryo Transfer Cycle

NACompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

November 21, 2021

Study Completion Date

November 21, 2021

Conditions
InfertilityIVFProgesterone
Interventions
OTHER

Normal Progesterone group

Progesteron supplementation was initiated by the use of 100 mg of a vaginal progesterone tablet two times daily (Lutinus, Ferring Pharmaceuticals) plus 250 mg of intramuscular hydroxyprogesterone caproate in oil twice a week (IMHPC) as luteal phase support (referred to as day 0 of progesterone administration).

OTHER

Low Progesterone group

Progesterone level \<10 ng/mL on ET day. If serum progesterone levels were \<10 ng/ml at ET day, 25 mg/d of SC progesterone daily (Prolutex) was given to patients and ET was performed on the same day and the blood sample was taken 2 days later to check serum progesterone levels.

Trial Locations (2)

Unknown

Acıbadem Kozyatağı Hospital, Istanbul

Bezmialem Foundation University, Istanbul

All Listed Sponsors
lead

Bezmialem Vakif University

OTHER

NCT04769401 - Effects of E2, P4 and LH Levels on the Day of Transfer and Endometrial Cavity Thickness on Implantation Success in Patients With Frozen-thawed Embryo Transfer Cycle | Biotech Hunter | Biotech Hunter